Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions

Establishment and characterization of Mardin-Darby canine kidney cells stably expressing human organic anion transporters

(2010) Ho Jung Shin et al.   ARCHIVES OF PHARMACAL RESEARCH

Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism

(2009) Yi-Jing He et al.   CLINICA CHIMICA ACTA

Culture Period-Dependent Change of Function and Expression of ATP-Binding Cassette Transporters in Caco-2 Cells

(2009) E. Kamiyama et al.   DRUG METABOLISM AND DISPOSITION

Olmesartan medoxomil: recent clinical and experimental acquisitions

(2009) Maurizio Destro et al.   Expert Opinion on Drug Metabolism & Toxicology

The Need for Multiple Doses of 400 mg Ketoconazole as a Precipitant Inhibitor of a CYP3A Substrate in an In Vivo Drug-Drug Interaction Study

(2009) Charles Oo et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Quantitative Evaluation of Pharmacokinetic Inhibition of CYP3A Substrates by Ketoconazole: A Simulation Study

(2009) Ping Zhao et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism

(2008) Suttasinee Suwannakul et al.   JOURNAL OF HUMAN GENETICS

The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15

(2008) Jian Wei Deng et al.   Pharmacogenetics and Genomics